[Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
D001241:Aspirin / Q000008:administration & dosage*; D004176:Dipyridamole / Q000008:administration & dosage*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000517:prevention & control; D010974:Platelet Aggregation / Q000187:drug effects*; D012008:Recurrence; D013442:Sulfinpyrazone / Q000008:administration & dosage*
D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Gli antiaggreganti piastrinici nel paziente postinfartuato: perché, quale ed in quali dosi?